187 related articles for article (PubMed ID: 23906794)
1. A novel mechanism of XIAP degradation induced by timosaponin AIII in hepatocellular carcinoma.
Wang N; Feng Y; Zhu M; Siu FM; Ng KM; Che CM
Biochim Biophys Acta; 2013 Dec; 1833(12):2890-2899. PubMed ID: 23906794
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of autophagy enhances timosaponin AIII-induced lung cancer cell apoptosis and anti-tumor effect in vitro and in vivo.
Liu J; Deng X; Sun X; Dong J; Huang J
Life Sci; 2020 Sep; 257():118040. PubMed ID: 32622943
[TBL] [Abstract][Full Text] [Related]
3. Timosaponin A‑III induces autophagy of T‑cell acute lymphoblastic leukemia Jurkat cells via inhibition of the PI3K/Akt/mTOR pathway.
Wang H; Dong R; Fan WW; Zheng XC; Li AM; Wang WD
Oncol Rep; 2019 May; 41(5):2937-2944. PubMed ID: 30896824
[TBL] [Abstract][Full Text] [Related]
4. Timosaponin AIII is preferentially cytotoxic to tumor cells through inhibition of mTOR and induction of ER stress.
King FW; Fong S; Griffin C; Shoemaker M; Staub R; Zhang YL; Cohen I; Shtivelman E
PLoS One; 2009 Sep; 4(9):e7283. PubMed ID: 19789631
[TBL] [Abstract][Full Text] [Related]
5. Timosaponin AIII, a steroidal saponin, exhibits anti-tumor effect on taxol-resistant cells in vitro and in vivo.
Song XY; Han FY; Chen JJ; Wang W; Zhang Y; Yao GD; Song SJ
Steroids; 2019 Jun; 146():57-64. PubMed ID: 30951756
[TBL] [Abstract][Full Text] [Related]
6. Timosaponin AIII mediates caspase activation and induces apoptosis through JNK1/2 pathway in human promyelocytic leukemia cells.
Huang HL; Chiang WL; Hsiao PC; Chien MH; Chen HY; Weng WC; Hsieh MJ; Yang SF
Tumour Biol; 2015 May; 36(5):3489-97. PubMed ID: 25542232
[TBL] [Abstract][Full Text] [Related]
7. Timosaponin A-III induces autophagy preceding mitochondria-mediated apoptosis in HeLa cancer cells.
Sy LK; Yan SC; Lok CN; Man RY; Che CM
Cancer Res; 2008 Dec; 68(24):10229-37. PubMed ID: 19074891
[TBL] [Abstract][Full Text] [Related]
8. Timosaponin AIII inhibits migration and invasion of A549 human non-small-cell lung cancer cells via attenuations of MMP-2 and MMP-9 by inhibitions of ERK1/2, Src/FAK and β-catenin signaling pathways.
Jung O; Lee J; Lee YJ; Yun JM; Son YJ; Cho JY; Ryou C; Lee SY
Bioorg Med Chem Lett; 2016 Aug; 26(16):3963-7. PubMed ID: 27422337
[TBL] [Abstract][Full Text] [Related]
9. Novel Timosaponin AIII-Based Multifunctional Liposomal Delivery System for Synergistic Therapy Against Hepatocellular Carcinoma Cancer.
Zhang L; Zhang S; Jiang M; Lu L; Ding Y; Ma N; Zhao Y; Xuchen S; Zhang N
Int J Nanomedicine; 2021; 16():5531-5550. PubMed ID: 34429598
[TBL] [Abstract][Full Text] [Related]
10. Polyphyllin I induced-apoptosis is enhanced by inhibition of autophagy in human hepatocellular carcinoma cells.
Shi YM; Yang L; Geng YD; Zhang C; Kong LY
Phytomedicine; 2015 Dec; 22(13):1139-49. PubMed ID: 26598912
[TBL] [Abstract][Full Text] [Related]
11. Antibody-modified liposomes for tumor-targeting delivery of timosaponin AIII.
Lu L; Ding Y; Zhang Y; Ho RJ; Zhao Y; Zhang T; Guo C
Int J Nanomedicine; 2018; 13():1927-1944. PubMed ID: 29636610
[TBL] [Abstract][Full Text] [Related]
12. hnRNP K suppresses apoptosis independent of p53 status by maintaining high levels of endogenous caspase inhibitors.
Xiao Z; Ko HL; Goh EH; Wang B; Ren EC
Carcinogenesis; 2013 Jul; 34(7):1458-67. PubMed ID: 23455382
[TBL] [Abstract][Full Text] [Related]
13. Induction of mitochondria-dependent apoptosis in HepG2 human hepatocellular carcinoma cells by timosaponin A-III.
Nho KJ; Chun JM; Kim HK
Environ Toxicol Pharmacol; 2016 Jul; 45():295-301. PubMed ID: 27344126
[TBL] [Abstract][Full Text] [Related]
14. Timosaponin AIII induces apoptosis and autophagy in human melanoma A375-S2 cells.
Wang Y; Xu L; Lou LL; Song SJ; Yao GD; Ge MY; Hayashi T; Tashiro SI; Onodera S; Ikejima T
Arch Pharm Res; 2017 Jan; 40(1):69-78. PubMed ID: 27271334
[TBL] [Abstract][Full Text] [Related]
15. Timosaponin A-III reverses multi-drug resistance in human chronic myelogenous leukemia K562/ADM cells via downregulation of MDR1 and MRP1 expression by inhibiting PI3K/Akt signaling pathway.
Chen JR; Jia XH; Wang H; Yi YJ; Wang JY; Li YJ
Int J Oncol; 2016 May; 48(5):2063-70. PubMed ID: 26984633
[TBL] [Abstract][Full Text] [Related]
16. Activation of autophagy of aggregation-prone ubiquitinated proteins by timosaponin A-III.
Lok CN; Sy LK; Liu F; Che CM
J Biol Chem; 2011 Sep; 286(36):31684-96. PubMed ID: 21757721
[TBL] [Abstract][Full Text] [Related]
17. Fangchinoline induces autophagic cell death via p53/sestrin2/AMPK signalling in human hepatocellular carcinoma cells.
Wang N; Pan W; Zhu M; Zhang M; Hao X; Liang G; Feng Y
Br J Pharmacol; 2011 Sep; 164(2b):731-42. PubMed ID: 21418191
[TBL] [Abstract][Full Text] [Related]
18. Regulation of SIRT1/AMPK axis is critically involved in gallotannin-induced senescence and impaired autophagy leading to cell death in hepatocellular carcinoma cells.
Kwon HY; Kim JH; Kim B; Srivastava SK; Kim SH
Arch Toxicol; 2018 Jan; 92(1):241-257. PubMed ID: 28676953
[TBL] [Abstract][Full Text] [Related]
19. Sann-Joong-Kuey-Jian-Tang inhibits hepatocellular carcinoma Hep-G2 cell proliferation by increasing TNF-α, Caspase-8, Caspase- 3 and Bax but by decreasing TCTP and Mcl-1 expression in vitro.
Chen YL; Yan MY; Chien SY; Kuo SJ; Chen DR; Cheng CY; Su CC
Mol Med Rep; 2013 May; 7(5):1487-93. PubMed ID: 23525225
[TBL] [Abstract][Full Text] [Related]
20. ASPP2 enhances chemotherapeutic sensitivity through the down-regulation of XIAP expression in a p53 independent manner in hepatocellular carcinoma.
Yang T; Gao Y; Liu D; Wang Y; Wu J; Liu X; Shi Y; Chen D
Biochem Biophys Res Commun; 2019 Jan; 508(3):769-774. PubMed ID: 30528232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
